QI
ANIP icon

QS Investors’s ANI Pharmaceuticals ANIP Stock Holding History

QS Investors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,700
Closed -$302K – 1186
2020
Q3 		$302K Sell
10,700
-24,400
-70% -$727K ﹤0.01% 919
2020
Q2 		$1.14M Hold
35,100
– – 0.02% 687
2020
Q1 		$1.43M Buy
35,100
+200
+0.6% +$10.6K 0.02% 554
2019
Q4 		$2.1M Buy
+34,900
New +$2.31M 0.02% 573
2015
Q2 		– Sell
-4,792
Closed -$300K – 1408
2015
Q1 		$300K Buy
+4,792
New +$291K ﹤0.01% 985

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

QS Investors's ANIP Position: Q4 2020 in Review

QS Investors sold out of ANI Pharmaceuticals (ANIP) in Q4 2020, closing a stake of 10,700 shares — an estimated $302K sold.

QS Investors first reported a position in ANIP in Q1 2015 and held it in 5 quarters. The position peaked at $2.1M in Q4 2019. 117 funds tracked by Wall St. Rank hold ANIP as of Q4 2020.

  • QS Investors reported no remaining ANI Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • QS Investors sold 10,700 ANI Pharmaceuticals shares in Q4 2020, an estimated $302K.
  • QS Investors first reported a position in ANI Pharmaceuticals in Q1 2015 and held it in 5 quarters.
  • QS Investors's ANI Pharmaceuticals position peaked at $2.1M in Q4 2019.
  • 117 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.